Sanofi US News

- Sarilumab, Given Subcutaneously Every Other Week, Met All Three Co-Primary Endpoints -

- Findings Consistent with Known Post-Prandial Effect of Lyxumia Supporting Combination with Basal Insulin -

- Treats Seasonal and Year-round Nasal Allergy Symptoms in Adults and Children -

- Connect & Coach™ Awarded $100,000 to Further Develop its Novel Solution to Help Improve Health Outcomes for People Living with Diabetes -

Growth platforms(2) sales increased 8.6%(3)

Pathway to Stop Diabetes to provide funding for innovative diabetes researchers

- Sanofi US to Donate Up to $100,000 to Patient Organizations -

- NBA All-Stars Andre Iguodala and Danny Granger and Seven-Time WNBA All-Star Tamika Catchings to Help Raise Awareness about Diabetes -

-- Product acquisition further strengthens Consumer Healthcare Division of Sanofi US --

Pathway to Stop Diabetes to Provide Funding for Innovative Diabetes Researchers

- New Data Presented at American Society of Hematology Annual Meeting Show Activity Against Disease and Symptom Alleviation -

Response Includes Contribution to Three New Jersey Area Organizations

Growth Platforms(2) reached over 70% of sales

Establishment of joint project teams will leverage strengths of academic and industry cross-organizational expertise in all stages of translational research

- Goal is to select novel clinical development candidates to help stop the global pandemic -

-- Breakthrough device design talks patients and caregivers through the injection process --

Novel Ideas Sought on How to Better Engage Patients in Their Health